Eli Lilly and Company (LLY)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
| Previous close | 336.13 |
| Open | 327.80 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1100 |
| Day's range | 323.26 - 336.22 |
| 52-week range | 276.83 - 375.25 |
| Volume | |
| Avg. volume | 3,161,921 |
| Market cap | 318.655B |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | 48.07 |
| EPS (TTM) | 6.96 |
| Earnings date | 27 Apr 2023 |
| Forward dividend & yield | 4.52 (1.36%) |
| Ex-dividend date | 14 Feb 2023 |
| 1y target est | 380.75 |
- Zacks
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- Zacks
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Sanofi, Regeneron, AbbVie, Roche and Eli Lilly are included in this Analyst Blog.
- Zacks
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
Sanofi's (SNY) Dupixent succeeds in a pivotal study for COPD. FDA gives CRL to AbbVie's (ABBV) Parkinson's disease therapy, ABBV-951
© 2023 Yahoo. All rights reserved.
